More importantly, AREG enhanced the resistance of PCa cells against MIT, a DNA‐targeting chemotherapeutic agent for human malignancies including PCa (Bergstrom et al., 2017; Eisenberger et al., 2017; Figure S3e). Here, AREG is linked to posterior cortical atrophy.